Search filters

List of works by Marina Garassino

A lesson from vorinostat in pleural mesothelioma

scientific article published on 20 March 2015

A mono-institutional prospective study on the effectiveness of a specialist psychotherapeutic intervention (POI) started at the diagnosis of cancer ⬇️

scientific article published on January 22, 2011

ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations

scientific article published on 25 August 2016

Across the universe of K-RAS mutations in non-small-cell-lung cancer.

scientific article published on January 2014

Afatinib for lung cancer: let there be light?

scientific article

Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?

scientific article published on February 2016

Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors

scientific article published on 19 November 2014

Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells.

scientific article published on 2 September 2015

Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?

scientific article published on 24 May 2016

Challenging Lung Carcinoma with Coexistent ΔNp63/p40 and Thyroid Transcription Factor-1 Labeling Within the Same Individual Tumor Cells

scientific article published in October 2015

Chemotherapy versus tyrosine kinase inhibitor in EGFR unselected population advanced non-small cell lung cancer still matter of debate?-An update incorporating the DELTA trial data

scientific article

Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules

scientific article published on 7 April 2016

Diagnosis and management of typical and atypical lung carcinoids

scientific article published on 18 February 2016

Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge

scientific article published on 26 August 2015

Do we really need another epidermal growth factor receptor tyrosine kinase inhibitor in first-line treatment for patients with non-small-cell lung cancer and EGFR mutations?

scientific article published on 03 February 2014

Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?: A Multicenter Retrospective Analysis of 1365 Consecutive Patients

article

Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.

scientific article

Doing more with less: fluorescence in situ hybridization and gene sequencing assays can be reliably performed on archival stained tumor tissue sections

scientific article published on 27 January 2016

EGFR mutations and EGFR tyrosine kinase inhibitors.

scientific article

Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders.

scientific article published on 10 July 2013

Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future

scientific article published on December 2016

Evaluation of safety and efficacy of tivantinib in the treatment of inoperable or recurrent non-small-cell lung cancer

scientific article published on 17 January 2013

Fatal case of hepatic portal venous gas following palliative stenting and chemotherapy for occlusive advanced colorectal cancer

G48A, a New KRAS Mutation Found in Lung Adenocarcinoma.

scientific article published on 4 April 2016

Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung Cancer.

scientific article

Is the chemotherapy era in advanced non-small cell lung cancer really over? Maybe not yet.

scientific article published on 15 March 2016

Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first-line treatment for patients harboring EGFR mutations

scientific article

KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy

scientific article published on 15 September 2015

Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy number

scientific article published in December 2013

Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis.

scientific article published on 25 February 2010

Maintenance therapy in NSCLC: why? To whom? Which agent? ⬇️

scientific article

Male breast cancer: clinical features and multimodal treatment in a retrospective survey analysis at Italian centers

scientific article published in September 2013

Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer

scientific article

Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene.

scientific article

New anti-emetic treatments.

scientific article published on July 2007

New findings on thymic epithelial tumors: Something is changing.

scientific article

New strategies in colon cancer adjuvant therapy

scientific article published on 01 June 2006

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

scientific article (publication date: 9 July 2015)

ORAL01.04: Phase II Trial of Atezolizumab for Patients with PD-L1-Selected Advanced NSCLC (BIRCH): Updated Efficacy and Exploratory Biomarker Results: Topic: Medical Oncology

scientific article

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.

scientific article published on 6 December 2016

Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution.

scientific article published on 29 July 2008

Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: a multi-institutional retrospective analysis

scientific article

Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors.

scientific article

Perioperative or postoperative therapy for resectable gastric cancer?

scientific article published on 01 July 2008

Phase III, randomized, open-label study of durvalumab (MEDI4736) in combination with tremelimumab or durvalumab alone versus platinum-based chemotherapy in first-line treatment of patients with advanced/metastatic NSCLC: MYSTIC.

scientific article published on 4 November 2015

Predicting response of molecular targeted therapies: a still possible challenge?

scientific article published on 21 February 2008

Predictive models in palliative care.

scientific article published on July 2009

Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients.

scientific article

Reply to FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS-mutated tumours in the randomised German AIO study KRK-0306

scientific article published on 08 August 2012

Response of thymoma to cetuximab

scientific article published on 01 May 2007

Reversible palpebral ptosis following oxaliplatin infusion.

scientific article published on 29 October 2007

Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis.

scientific article published on 13 December 2010

Role of Cetuximab in the Treatment of Patients With NSCLC: Are We Throwing Out the Baby With the Bath Water?

scientific article published on 28 June 2010

Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)

scientific article

Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.

scientific article

Should KRAS mutations be considered an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab?

scientific article published on 01 May 2008

Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem.

scientific article published on 2 May 2016

Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?

scientific article

Targeted therapies in small cell lung cancer: a review

scientific article

Targeted therapy-induced diarrhea: A review of the literature.

scientific article published on 05 December 2013

Targeting the MET gene for the treatment of non-small-cell lung cancer

scientific article published on December 2013

Testing epidermal growth factor receptor mutations in patients with non-small-cell lung cancer to choose chemotherapy: the other side of the coin.

scientific article

The 5'UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs

scientific article published on 14 December 2016

The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations

scientific article published in 2022

The impact of personalized medicine on survival: comparisons of results in metastatic breast, colorectal and non-small-cell lung cancers

scientific article published on 25 September 2013

Thymoma and thymic carcinomas

scientific article published on 19 January 2016

To target or not to target, that is the question.

scientific article

Treatment of lung large cell neuroendocrine carcinoma.

scientific article published on 4 March 2016

Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.

scientific article

[Locoregional therapy in hepatic metastases of colorectal cancer]

scientific article published on 01 January 2001

ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization

scientific article published on 12 March 2013

Paulina is supported by:

About Paulina

Help